Menu
Back to Journals » Vascular Health and Risk Management » Volume 16
Review
Understanding the early mortality benefit observed in the PARADIGM-HF trial: considerations for the management of heart failure with sacubitril/valsartan
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 13,256 | Dovepress* | 9,173+ | 1,847 | 11,020 | |
| PubMed Central* | 4,083 | 779 | 4,862 | ||
| Totals | 13,256 | 2,626 | 15,882 | ||
| *Since 16 January 2020 | |||||
View citations on PubMed Central and Google Scholar